|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
4338358 |
| 003 |
ICU |
| 005 |
20031020110400.0 |
| 008 |
000724s2000 enka b 001 0 eng d |
| 020 |
|
|
|a 1853173177
|
| 035 |
|
|
|a MAHGBOY87275-B
|
| 035 |
|
|
|a (MH)MHBOY87275HU
|
| 035 |
|
|
|a (OCoLC)44641409
|
| 035 |
|
|
|a 90063672
|
| 040 |
|
|
|a *OS2*
|c *OS2*
|d MBCo
|d CStRLIN
|d OCoLC
|d OrLoB-B
|
| 050 |
|
4 |
|a RC271.A35
|b S77 2000
|
| 245 |
0 |
0 |
|a Strategies in adjuvant therapy /
|c edited by John M. Kirkwood.
|
| 260 |
|
|
|a London :
|b Martin Dunitz ;
|a Malden, Mass. :
|b Distributed in the United States by Blackwell Science, Inc.,
|c 2000.
|
| 300 |
|
|
|a xi, 255 p. :
|b ill. ;
|c 25 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t PCR-based detection of malignant cells: Towards molecular staging? /
|r Ulrich Keilholz, Nicole Max and Benjamin Spike /
|r [et al.] --
|g 2.
|t Adjuvant therapy for colorectal cancers /
|r Scott Wadler --
|g 3.
|t Malignant lymphoma /
|r Timothy M. Kuzel, Ann E. Traynor and Steven T. Rosen --
|g 4.
|t Low-dose IFN-[alpha] adjuvant therapy in intermediate- and high-risk melanoma /
|r Jean-Jacques Grob --
|g 5.
|t Adjuvant therapy of melanoma /
|r Sanjiv S. Agarawala and John M. Kirkwood --
|g 6.
|t Prostatic carcinoma /
|r Michael R. Curtis, John A. Heaney and Robert J. Amdur /
|r [et al.] --
|g 7.
|t Renal cell carcinoma /
|r Thomas Schwaab and Jens Atzpodien --
|g 8.
|t Adjuvant biological therapy of head and neck cancer /
|r Julie G. Izzo, Fadlo R. Khuri and Waun Ki Hong --
|g 9.
|t Adjuvant therapies for non-small cell lung cancer /
|r Karin V. Mattson --
|g 10.
|t Breast cancer: Biologic therapy /
|r Margaret von Mehren and Louis M. Weiner --
|g 11.
|t Soft tissue sarcoma /
|r Alexander M. M. Eggermont.
|
| 650 |
1 |
2 |
|a Adjuvants, Immunologic.
|
| 650 |
2 |
2 |
|a Neoplasms
|x drug therapy.
|
| 650 |
|
7 |
|a Cancer
|x Adjuvant treatment.
|2 fast
|0 http://id.worldcat.org/fast/fst00845318
|
| 700 |
1 |
|
|a Kirkwood, John M.
|0 http://id.loc.gov/authorities/names/n95801973
|1 http://viaf.org/viaf/32115595
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 8c727cfd-7257-5de6-8b44-9bc0b399f0b6
|s 8f7c1d02-fda6-5342-b8b5-e92a4241a8a6
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.A35 S77 2000
|l ASR
|c ASR-SciASR
|i 4489958
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.A35 S77 2000
|l ASR
|c ASR-SciASR
|e CRERAR
|b 56474603
|i 6924115
|
